Skip to main content
Clinical Trials/CTRI/2023/11/059886
CTRI/2023/11/059886
Not yet recruiting
Phase 2

Comprehensive (Pharmaceutical, Analytical and Clinical) Study of Phalatrikadi Ghan in the management of Non-Alcoholic Fatty Liver Disease (NAFLD) - NI

Institute of Medical Science Department of Rasa Shastra evum Bhaishajya Kalpana0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Institute of Medical Science Department of Rasa Shastra evum Bhaishajya Kalpana
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Institute of Medical Science Department of Rasa Shastra evum Bhaishajya Kalpana

Eligibility Criteria

Inclusion Criteria

  • Patient of either sex, between the age group of 20 to 60 yrs, Sonologically diagnosed cases of fatty liver.
  • Fatty liver of grade I, II, III will be enrolled for clinical trial.
  • Patients having any of the components of metabolic syndrome, i.e., obesity, hypertension, diabetes mellitus, hypertriglyceridemia.
  • BMI \>25, presenting with the symptoms of indigestion, abdominal discomfort, flatulence, etc.

Exclusion Criteria

  • Alcoholic stetohepatitis, Hepatitis B and C, cirrhosis of liver, jaundice, pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials